FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/18/2024
Back to search
Official data from USPTO
SYNBIOFF
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
03/18/2024
Classification
Registered
Trademark type
Word
Nice classes
1, 5
Filing date
03/01/2022
Registration date
11/21/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/21/2023
Last transaction
11/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
IT
Examiner
COLEMAN, CIMMERIAN
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SYNBALANCE SRL
Representatives
Robert S. Broder Collard & Roe, P.C.
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Probiotic bacteria for use in the manufacture of pharmaceuticals and nutraceuticals
Class 5
Probiotic bacterial formulations for medical use; probiotic supplements; pharmaceutical and medicinal preparations for use in the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; pharmaceutical and medicinal preparations for use in the treatment of gastro-intestinalimmunity and uro-genital disordershyperlipidemiasunburninfectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disordersdamaged skin and tissueeye diseases and conditionsskin disordersdiabeteserectile dysfunctionbone diseasesimmune system related diseases and disordersallergieshypertensionepidermisrespiratory diseasescardiovascular disordersviralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disordersrespiratory diseasesasthmaallergic rhinitisviral infectionsgastro-intestinal diseaseshalitosisviral diseasesautoimmune diseases; pharmaceutical preparations for skin care; pharmaceutical preparations for use in urology; pharmaceutical preparations for the prevention of gastro-intestinal and urogenital infectionsseasonal illnesscommon coldscardiovascular diseasegastro-intestinal or local dysbiosisallergies; pharmaceutical preparations for wounds; pharmaceutical preparations for animal skincare; pharmaceutical preparations acting on the central nervous system; dermatological pharmaceutical products; pharmaceutical skin lotions; pharmaceutical products for skin care for animals; anti-diabetic pharmaceuticals; ferments for pharmaceutical purposes; pharmaceutical agents affecting metabolism; ferments for pharmaceutical purposesfor gastro-intestinalimmunity and uro-genital disorders; digestives for pharmaceutical purposes; pharmaceutical preparation for skin care; pharmaceuticalslipid lowering agents; milk ferments for pharmaceutical purposes
Publications
History of USPTO decisions and trademark events.
30 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/22/2024
FIMP
FINAL DISPOSITION PROCESSED
02/22/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/21/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/21/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/21/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/16/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/27/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/27/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/05/2023
PUBO
PUBLISHED FOR OPPOSITION
09/05/2023
GPNX
NOTIFICATION PROCESSED BY IB
09/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/16/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/16/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/16/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/28/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/27/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/26/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/26/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/27/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/14/2023
RFNT
REFUSAL PROCESSED BY IB
03/15/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/22/2023
RFRR
REFUSAL PROCESSED BY MPU
02/22/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/27/2022
CNRT
NON-FINAL ACTION WRITTEN
12/26/2022
DOCK
ASSIGNED TO EXAMINER
12/13/2022
MAFR
APPLICATION FILING RECEIPT MAILED
04/26/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/22/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/21/2022
Continuous trademark protection
Get notified about every new filing that threatens SYNBIOFF or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.